EXHIBIT INDEX
Exhibit
Number Description
2.1 Agreement and Plan of Merger, dated as of February 26, 1996, among
First Hawaiian, Inc., ANB Financial Corporation and ANB Acquisition
Corporation
4.1 Certificate of Incorporation of First Hawaiian, Inc., as amended
through May 9, 1996 (incorporated by reference to Exhibit 3 of
Registrant's Quarterly Report on Form 10-Q, for the quarter ended
March 31, 1996)
4.2 Bylaws of First Hawaiian, Inc. (incorporated by reference to Exhibit 3
of Registrant's Annual Report on Form 10-K for the year ended December
31, 1987) (Commission file number 0-7949)
*5 Opinion of Simpson Thacher & Bartlett regarding the legality of
securities being registered
*8.1 Opinion of Simpson Thacher & Bartlett as to tax matters
*8.2 Opinion of Knight, Vale & Gregory, Inc., P.S. as to tax matters
23.1 Consent of Coopers & Lybrand L.L.P. as to financial statements of
First Hawaiian, Inc.
*23.2 Consent of Simpson Thacher & Bartlett (contained in exhibits 5 and
8.1)
*23.3 Consent of Knight, Vale & Gregory Inc., P.S. (contained in exhibit
8.2)
23.4 Consent of Ragen MacKenzie Incorporated (contained in Annex II to the
Proxy Statement/Prospectus)
24 Powers of Attorney
99.1 Chairman's Letter to Shareholders of ANB Financial Corporation
99.2 Notice of Annual Meeting of Shareholders of ANB Financial Corporation
99.3 Form of Proxy for the Annual Meeting of Shareholders of ANB Financial
Corporation
99.4 Opinion of Ragen MacKenzie Incorporated (included as Annex II to the
Proxy Statement/Prospectus)
__________________
* To be filed by amendment
EXHIBIT 2.1
AGREEMENT AND PLAN OF MERGER
dated as of February 26, 1996
among
FIRST HAWAIIAN, INC.,
ANB ACQUISITION CORPORATION
and
ANB FINANCIAL CORPORATION
TABLE OF CONTENTS
Page
ARTICLE I
THE MERGER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.1 The Merger . . . . . . . . . . . . . . . . . . . 8
1.2 Effective Time of the Merger . . . . . . . . . . 8
1.3 Corporate Organization . . . . . . . . . . . . . 8
(a) Articles of Incorporation . . . . . . . 8
(b) By-Laws . . . . . . . . . . . . . . . . 8
(c) Board of Directors and Officers of
Surviving Corporation . . . . . . . . 8
1.4 Effect of the Merger on the Securities of the
Constituent Corporations . . . . . . . . . . . 8
(a) Company Common Stock . . . . . . . . . . . 9
(b) Certain Definitions . . . . . . . . . . . 9
(c) Cancellation of Treasury Stock and FHI-
Owned Stock, etc. . . . . . . . . . . . 10
(d) Options. . . . . . . . . . . . . . . . . . 10
(e) Sub Common Stock . . . . . . . . . . . . . 11
(f) FHI Common Stock . . . . . . . . . . . . . 11
(g) Anti-Dilution . . . . . . . . . . . . . . 11
(h) Dissenting Stock . . . . . . . . . . . . . 11
(i) Determination of Determination Date
Book Value Per Share . . . . . . . . . . 12
(j) Adjustment of Determination Date Book
Value Per Share . . . . . . . . . . . . 12
1.5 Exchange of Certificates . . . . . . . . . . . . . 13
(a) Exchange Agent . . . . . . . . . . . . . . 13
(b) Exchange Procedures . . . . . . . . . . . 13
(c) Distributions with Respect to
Unexchanged Shares; Voting . . . . . . . 14
(d) No Further Ownership Rights in Company
Common Stock . . . . . . . . . . . . . . 14
(e) No Fractional Shares . . . . . . . . . . . 15
(f) Termination of Exchange Fund . . . . . . . 15
(g) No Liability . . . . . . . . . . . . . . . 15
ARTICLE II
THE CLOSING . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.1 Closing Date . . . . . . . . . . . . . . . . . . . 16
2.2 Procedure . . . . . . . . . . . . . . . . . . . . 16
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF COMPANY . . . . . . . . . . . . . . . . 16
3.1 Organization, Etc. . . . . . . . . . . . . . . 16
3.2 Non-Contravention; Binding Effect . . . . . . . 17
3.3 No Consent . . . . . . . . . . . . . . . . . . . 17
3.4 Compliance with Laws . . . . . . . . . . . . . . 18
3.5 Capitalization . . . . . . . . . . . . . . . . . 19
3.6 Subsidiaries . . . . . . . . . . . . . . . . . . 19
3.7 Charter Documents; Management . . . . . . . . . 20
3.8 Financial Statements and Reports . . . . . . . . 20
3.9 Properties . . . . . . . . . . . . . . . . . . . 21
3.10 Absence of Certain Changes . . . . . . . . . . . 22
3.11 Material Contracts . . . . . . . . . . . . . . . 24
3.12 Litigation . . . . . . . . . . . . . . . . . . . 24
3.13 Regulatory Applications . . . . . . . . . . . . 25
3.14 Taxes . . . . . . . . . . . . . . . . . . . . . 25
3.15 Employee Benefit Plans; ERISA . . . . . . . . . 27
3.16 Labor Relations . . . . . . . . . . . . . . . . 29
3.17 Employment and Similar Agreements; Obligations
Upon Change in Control . . . . . . . . . . . . 29
3.18 Broker's and Finder's Fees . . . . . . . . . . . 30
3.19 Hazardous Materials . . . . . . . . . . . . . . 30
3.20 Damage to Mortgaged Properties . . . . . . . . . 31
3.21 Shareholder Approval . . . . . . . . . . . . . . 31
3.22 Deposit Accounts . . . . . . . . . . . . . . . . 31
3.23 Trademarks, Etc. . . . . . . . . . . . . . . . 31
3.24 Disclosure . . . . . . . . . . . . . . . . . . . 32
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF FHI AND SUB . . . . . . . . . . . . . 32
4.1 Organization, Etc. . . . . . . . . . . . . . . 32
4.2 Non-Contravention; Binding Effect . . . . . . . 33
4.3 No Consent . . . . . . . . . . . . . . . . . . . 33
4.4 Compliance with Laws . . . . . . . . . . . . . . 34
4.5 Capitalization . . . . . . . . . . . . . . . . . 35
4.6 Charter Documents . . . . . . . . . . . . . . . 35
4.7 SEC Documents . . . . . . . . . . . . . . . . . 35
4.8 Absence of Certain Changes . . . . . . . . . . . 36
4.9 Litigation . . . . . . . . . . . . . . . . . . . 36
4.10 Regulatory Applications . . . . . . . . . . . . 37
4.11 Broker's and Finder's Fees . . . . . . . . . . . 37
4.12 Shareholder Approval . . . . . . . . . . . . . . 37
ARTICLE V
COVENANTS OF FHI, SUB AND COMPANY . . . . . . . . . . . . . . . . . . . 37
5.1 Covenants by FHI, Sub and Company . . . . . . . 37
(a) Filings and Approvals . . . . . . . . . 37
(b) Registration Statement . . . . . . . . . 38
(c) Reasonable Best Efforts . . . . . . . . 39
(d) Access . . . . . . . . . . . . . . . . . 39
5.2 Affirmative Covenants of Company . . . . . . . . 39
(a) Conduct of Business . . . . . . . . . . 39
(b) Delivery of Financial Statements . . . . 40
(c) Meeting of Shareholders . . . . . . . . 40
(d) Proxy Statement . . . . . . . . . . . . 40
5.3 Negative Covenants of Company . . . . . . . . . 40
(a) Charter . . . . . . . . . . . . . . . . 40
(b) Dividends . . . . . . . . . . . . . . . 40
(c) Issuance of Securities . . . . . . . . . 41
(d) Reclassifications or Repurchases . . . . 41
(e) Business Combinations . . . . . . . . . 41
(f) Contracts; Employee Matters . . . . . . 41
(g) Indebtedness . . . . . . . . . . . . . . 41
(h) Investments . . . . . . . . . . . . . . 42
(i) Business Practices . . . . . . . . . . . 42
5.4 Notification . . . . . . . . . . . . . . . . . . 42
5.5 No Shopping . . . . . . . . . . . . . . . . . . 42
5.6 Indemnification . . . . . . . . . . . . . . . . 43
5.7 Employees . . . . . . . . . . . . . . . . . . . 45
5.8 Affiliates . . . . . . . . . . . . . . . . . . . 45
5.9 Additional Covenants of Company . . . . . . . . 46
ARTICLE VI
CONDITIONS TO CLOSING . . . . . . . . . . . . . . . . . . . . . . . . . 47
6.1 Conditions to Company's Obligation to Close . . 47
(a) Continued Accuracy of Representations
and Warranties; Performance of
Covenants . . . . . . . . . . . . . . 47
(b) Regulatory Approvals . . . . . . . . . . 47
(c) Shareholder Approval . . . . . . . . . . 47
(d) No Injunction . . . . . . . . . . . . . 47
(e) Opinions of Counsel . . . . . . . . . . 47
(f) No Resolution Amendments . . . . . . . . 48
(g) Effectiveness of Registration Statement 48
(h) Blue-Sky Permits . . . . . . . . . . . . 48
(i) Tax Opinion . . . . . . . . . . . . . . 48
6.2 Conditions to FHI's and Sub's Obligation to
Close . . . . . . . . . . . . . . . . . . . . . 48
(a) Continued Accuracy of Representations
and Warranties; Performance of
Covenants . . . . . . . . . . . . . . 48
(b) Regulatory Approvals . . . . . . . . . . 48
(c) Shareholder Approval . . . . . . . . . . 49
(d) No Injunction . . . . . . . . . . . . . 49
(e) Opinions of Counsel . . . . . . . . . . 49
(f) No Resolution Amendments . . . . . . . . 49
(g) Consents Under Agreements . . . . . . . 49
(h) Good Standing and Tax Certificates . . . 49
(i) Resignation of Certain Directors . . . . 50
(j) Effectiveness of Registration Statement 50
(k) Blue-Sky Permits . . . . . . . . . . . . 50
(l) Tax Opinion . . . . . . . . . . . . . . 50
(m) Dissenting Stock . . . . . . . . . . . . 50
ARTICLE VII
TERMINATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
7.1 Termination . . . . . . . . . . . . . . . . . . 50
(a) Mutual Consent . . . . . . . . . . . . . 50
(b) No Shareholder Approval . . . . . . . . 50
(c) Regulatory Denials or Refusals . . . . . 50
(d) Company Breach . . . . . . . . . . . . . 51
(e) FHI or Sub Breach . . . . . . . . . . . 51
(f) Delay . . . . . . . . . . . . . . . . . 51
(g) Possible Adjustment . . . . . . . . . . 51
7.2 Effect of Termination . . . . . . . . . . . . . 51
ARTICLE VIII
GENERAL PROVISIONS . . . . . . . . . . . . . . . . . . . . . . . . . . 52
8.1 Notices . . . . . . . . . . . . . . . . . . . . 52
8.2 Governing Law . . . . . . . . . . . . . . . . . 53
8.3 Entire Agreement . . . . . . . . . . . . . . . . 53
8.4 Amendments and Waivers . . . . . . . . . . . . . 53
8.5 Counterparts . . . . . . . . . . . . . . . . . . 54
8.6 Interpretation of Agreement . . . . . . . . . . 54
8.7 Nonsurvival of Representations and Covenants . . 54
8.8 Fees and Expenses . . . . . . . . . . . . . . . 54
8.9 Definitions . . . . . . . . . . . . . . . . . . 55
8.10 Attorneys' Fees . . . . . . . . . . . . . . . . 55
8.11 Publicity . . . . . . . . . . . . . . . . . . . 56
8.12 Assignment . . . . . . . . . . . . . . . . . . . 56
8.13 Further Action . . . . . . . . . . . . . . . . . 56
8.14 Third Party . . . . . . . . . . . . . . . . . . 56
8.15 Gender; Number . . . . . . . . . . . . . . . . . 56
8.16 Schedules . . . . . . . . . . . . . . . . . . . 56
EXHIBITS
Exhibit A-1 . . . . . . . . . . . . Parties to Voting Agreement
Exhibit A-2 . . . . . . . . . . . . . . Form of Voting Agreement
Exhibit B . . . . . . . . . . . . . . . . . Affiliate Agreement
Exhibit C . . . . . . . . Form of Opinion of FHI General Counsel
Exhibit D . . . . . . . . . . Form of Opinion of Counsel to FHI
Exhibit E . . . . . . . . Form of Opinion of Counsel to Company
AGREEMENT AND PLAN OF MERGER
AGREEMENT AND PLAN OF MERGER, dated as of the 26th day of February,
1996 (this "Agreement"), among FIRST HAWAIIAN, INC., a Delaware corporation
("FHI"), ANB ACQUISITION CORPORATION, a Washington corporation and a direct
wholly-owned subsidiary of FHI ("Sub"), and ANB FINANCIAL CORPORATION, a
Washington corporation ("Company").
WHEREAS the board of directors of each of FHI, Sub and Company has
adopted resolutions approving this Agreement pursuant to which Sub shall be
merged with and into Company and Company shall become a wholly-owned direct
subsidiary of FHI (the "Merger");
WHEREAS the board of directors of each of FHI, Sub and Company has
determined that the Merger is consistent with, and in furtherance of, their
respective business strategies and goals;
WHEREAS, for Federal income tax purposes, it is intended that the
Merger shall qualify as a reorganization under the provisions of Section 368(a)
of the Internal Revenue Code of 1986, as amended (the "Code");
WHEREAS, for accounting purposes, it is intended that the Merger
shall be accounted for using the "purchase" accounting method;
WHEREAS, concurrently with the execution and delivery of this
Agreement, each of the shareholders of Company listed in Exhibit A-1 hereto has
entered into a Shareholder Voting Agreement in the form attached as Exhibit A-2
hereto pursuant to which such shareholder agreed to vote the shares of capital
stock of Company such shareholder owns or otherwise has the power to vote in
favor of approval of this Agreement and the Merger at any meeting of the
shareholders of Company held to consider and vote on such matters; and
WHEREAS FHI, Sub and Company desire to make certain representations,
warranties, covenants and agreements in connection with the Merger and also to
prescribe various conditions to the Merger;
NOW, THEREFORE, in consideration of the foregoing and the respective
representations, warranties, covenants and agreements set forth herein, the
parties agree as follows:
ARTICLE I
THE MERGER
1.1 The Merger. Upon the terms and subject to the conditions set
forth herein, at the Effective Time (as defined in Section 1.2), Sub shall be
merged with and into Company in accordance with Title 23B of the Revised Code
of Washington (the "RCW"). The separate existence of Sub shall thereupon cease
and Company shall be the surviving corporation in the Merger (the "Surviving
Corporation"). The Merger shall have the effects set forth in RCW
Section 23B.11.060.
1.2 Effective Time of the Merger. The Merger shall become effective
when properly executed articles of merger (the "Articles of Merger") are duly
filed with the Secretary of State of the State of Washington in accordance with
RCW Title 23B; provided, however, that, by mutual consent, the Articles of
Merger may provide for a later time of effectiveness of the Merger. When used
in this Agreement, the term "Effective Time" shall mean the date and time at
which the Articles of Merger are so filed (or such later time as is so provided
in the Articles of Merger).
1.3 Corporate Organization.
(a) Articles of Incorporation. The articles of incorporation of
Company, as in effect at the Effective Time, shall be the articles of
incorporation of the Surviving Corporation after the Effective Time unless and
until amended in accordance with its terms and as provided by law.
(b) By-Laws. The by-laws of Company, as in effect at the Effective
Time, shall be the by-laws of the Surviving Corporation unless and until
amended in accordance with their terms, the articles of incorporation of the
Surviving Corporation and as provided by law.
(c) Board of Directors and Officers of Surviving Corporation. The
board of directors of the Surviving Corporation shall consist of the directors
of Sub immediately prior to the Effective Time, who shall serve until their
respective successors are duly elected and qualified. The officers of Sub
immediately prior to the Effective Time shall be the officers of the Surviving
Corporation until their respective successors are duly elected and/or appointed
and qualified in the manner provided in the articles of incorporation and
by-laws of the Surviving Corporation, or as otherwise provided by law.
1.4 Effect of the Merger on the Securities of the Constituent
Corporations. As of the Effective Time, by virtue of the Merger and
without any action on the part of the holder of (i)
any shares of common stock, par value $1.00 per share, of Company
("Company Common Stock") or any other shares of capital stock of
Company or (ii) any shares of capital stock of Sub:
(a) Company Common Stock. Subject to Sections 1.5(e) and 7.1(g),
each share of Company Common Stock issued and outstanding at the Effective Time
(other than (i) shares of Company Common Stock to be cancelled pursuant to
Section 1.4(c) and (ii) shares of Company Common Stock held by any holder who
shall have taken the necessary steps under RCW Title 23B to exercise
dissenters' rights with respect to the Merger and demand payment for such
shares of Company Common Stock and who is otherwise entitled to such payment
under RCW Title 23B ("Dissenting Stock")) shall be converted into the number of
shares of Common Stock, par value $5.00 per share, of FHI ("FHI Common Stock")
determined by dividing (x) the product of (A) the Determination Date Book Value
Per Share and (B) 2.2 by (y) the Valuation Price (the quotient, as adjusted, if
applicable, pursuant to Sections 1.4(g), 1.4(j) and 7.1(g), being referred to
herein as the "Exchange Ratio"). The shares of FHI Common Stock so issuable
and any cash in lieu of fractional shares payable pursuant to Section 1.5(e)
shall be hereinafter referred to as the "Merger Consideration." From and after
the Effective Time, all such shares of Company Common Stock shall no longer be
outstanding and shall automatically be cancelled and retired and shall cease to
exist, and each certificate previously representing any such shares shall
thereafter represent the shares of FHI Common Stock into which such shares of
Company Common Stock have been converted. Certificates previously representing
shares of Company Common Stock shall be exchanged for certificates representing
whole shares of FHI Common Stock issued in consideration therefor upon the
surrender of such Company Common Stock certificates in accordance with Section
1.5, without interest.
(b) Certain Definitions. For purposes of this Agreement, the
following terms shall have the definitions indicated:
(i) "Average Closing Price" shall mean the average of the closing
prices per share of the FHI Common Stock reported on the NASDAQ National
Market System for the fifteen consecutive trading days commencing on (and
including) the Determination Date, as such closing prices are reported in
The Wall Street Journal.
(ii) "Determination Date" shall mean the 30th day preceding the
scheduled Closing Date.
(iii) "Determination Date Book Value Per Share" shall mean (A) the
consolidated stockholders' equity of Company as of the Determination Date,
which shall be determined in accordance with generally accepted accounting
principles ("GAAP") applied on a basis consistent with the accounting
principles and practices (including the application of fiscal year-end
procedures) used by Company in determining the consolidated stockholders'
equity of Company as of December 31, 1995, as reflected on the audited
consolidated balance sheet of Company referred to in Section 3.8, provided
that there shall be added to such stockholders' equity the aggregate of
the per share exercise prices for all shares of Company Common Stock
issuable upon exercise of Company Stock Options (as defined in Section
1.4(d)) outstanding as of the Determination Date divided by (B) the number
of shares of Company Common Stock outstanding as of the Determination Date
on a fully diluted basis. The Determination Date Book Value shall be
finally determined by the parties in accordance with the procedures set
forth in Section 1.4(i) and shall be subject to adjustment pursuant to
Section 1.4(j).
(iv) "Valuation Price" shall mean the Average Closing Price;
provided, however, that if the Average Closing Price is less than or equal
to $25.50, the Valuation Price shall be $25.50, and if the Average Closing
Price is more than or equal to $31.16, the Valuation Price shall be
$31.16.
(c) Cancellation of Treasury Stock and FHI-Owned Stock, etc. Except
as otherwise provided herein, each share of Company Common Stock which is
issued and outstanding immediately prior to the Effective Time and owned by FHI
or any direct or indirect wholly-owned subsidiary (as defined in Section 8.9)
of FHI (other than shares held by FHI or any such subsidiary in a fiduciary or
custodial capacity on behalf of persons other than Company or its subsidiaries
and other than shares acquired by FHI or any subsidiary of FHI in respect of
debts previously contracted), or which is held in the treasury of Company or by
any of its wholly-owned subsidiaries, shall be cancelled and retired and no FHI
Common Stock or other consideration shall be delivered in exchange therefor.
(d) Options. At least sixty days prior to the Closing Date, Company
shall cause the Board of Directors or Committee administering the ANB Financial
Corporation Employee Incentive Plan (i) to cause each outstanding stock option
to purchase shares of Company Common Stock (each, a "Company Stock Option")
issued thereunder that is not vested and fully exercisable to become vested and
become fully exercisable prior to the Closing Date and (ii) to cause each
Company Stock Option to terminate prior to the Effective Time, so that as of
the Effective Time no Company Stock Options are outstanding.
(e) Sub Common Stock. Each share of common stock of Sub issued and
outstanding immediately prior to the Effective Time shall be converted into and
become one validly issued, fully-paid and nonassessable share of common stock,
par value $1.00 per share, of the Surviving Corporation.
(f) FHI Common Stock. Each share of FHI Common Stock issued and
outstanding at the Effective Time shall remain issued and outstanding and shall
not be altered or changed by the Merger.
(g) Anti-Dilution. If FHI shall, at any time before the Effective
Time, (i) issue a dividend in shares of FHI Common Stock, (ii) combine the
outstanding shares of FHI Common Stock into a smaller number of shares, (iii)
subdivide the outstanding shares of FHI Common Stock or (iv) reclassify the FHI
Common Stock, then, in any such event (each, an "Adjustment Event"), the number
of shares of FHI Common Stock to be delivered to Company shareholders who are
entitled to receive shares of FHI Common Stock in exchange for shares of
Company Common Stock pursuant to this Article I shall be adjusted so that each
shareholder shall be entitled to receive such number of shares of FHI Common
Stock as such shareholder would have been entitled to receive as a result of
the Adjustment Event if the Effective Time had occurred immediately prior to
the happening of such Adjustment Event and appropriate and proportionate
adjustment shall be made to the calculations and number of shares of FHI Common
Stock to be issued as set forth in Section 1.4(a) and as set forth in
Section 1.4(d).
(h) Dissenting Stock. Notwithstanding the foregoing provisions or
any other provision of this Agreement to the contrary, Dissenting Stock shall
not be converted into the right to receive the Merger Consideration at or after
the Effective Time unless and until the holder of such Dissenting Stock
withdraws his or her assertion of dissenters' rights and demand for payment
with the consent of Company, if required, or becomes ineligible for payment for
such shares. If a holder of Dissenting Stock shall withdraw in writing his or
her demand for such payment with the consent of Company, if required, or shall
become ineligible for such payment (through failure to comply with the
applicable provisions of RCW Title 23B or otherwise), then, as of the later of
the Effective Time or the occurrence of such event, such holder's Dissenting
Stock shall be automatically converted into and represent the right to receive
the Merger Consideration (without interest thereon). Company shall give FHI
prompt notice of any demands for payment, withdrawals of such demands and any
other instruments served pursuant to RCW Ch. 23B.13 that are received by
Company. Company shall not voluntarily make any payment with respect to any
demands for payments and shall not, except with the prior written consent of
FHI, settle or offer to settle any such demands. Each holder of Dissenting
Stock shall have only such rights and remedies as are granted to such holder
under RCW
Ch. 23B.13. Dissenting Stock shall not, after the Effective Time, be
entitled to vote for any purpose or be entitled to the payment of dividends or
other distributions (except dividends or other distributions payable to
shareholders of record prior to the Effective Time).
(i) Determination of Determination Date Book Value Per Share.
Within five business days after the Determination Date, Company shall deliver
to FHI its determination of the Determination Date Book Value Per Share. FHI
and its independent accountants, Coopers & Lybrand, shall have access to the
workpapers of Company and its independent accountants, Knight Vale and Gregory
Inc., P.S., relating to the determination of the Determination Date Book Value
Per Share. Unless FHI notifies Company in writing within five business days
after receipt of Company's determination of the Determination Date Book Value
Per Share that it objects to such determination, specifying the basis for such
objection, Company's determination, as so delivered to FHI, shall be binding
upon the parties. If Company and FHI are unable to agree upon the
Determination Date Book Value Per Share within two business days after FHI's
written objection to Company's determination, the controversy shall be referred
to a nationally recognized independent public accounting firm selected by FHI
and reasonably acceptable to Company for a final determination thereof. Such
determination shall be binding upon the parties absent manifest error.
(j) Adjustment of Determination Date Book Value Per Share. To the
extent that Company experiences a net loss (as determined in accordance with
GAAP applied on a basis consistent with the accounting principles and practices
used by Company in preparing its audited consolidated income statement for the
fiscal year ended December 31, 1995 and as reasonably agreed to by FHI) during
the period commencing on the Determination Date and ending on the Closing Date,
the Determination Date Book Value Per Share as determined pursuant to Section
1.4(i) shall be reduced by the amount of such net loss and the Exchange Ratio
shall be recalculated after giving effect to such reduction. During the period
from the Determination Date through the Closing Date, Company shall provide FHI
and its independent accountants with such access to its financial records and
the workpapers of Company and its independent accountants as shall be
reasonably requested by FHI in order to review and agree with Company's
determination of net loss.
1.5 Exchange of Certificates.
(a) Exchange Agent. From and after the Effective Time, FHI shall
deposit, or shall cause to be deposited, with First Hawaiian Bank or such other
bank or trust company to be designated by FHI (the "Exchange Agent"), for the
benefit of the holders of certificates which immediately prior to the Effective
Time evidenced shares of Company Common Stock (the "Company Certificates"), for
exchange in accordance with this Article I, certificates representing the
shares of FHI Common Stock and cash in lieu of fractional shares (such cash and
certificates for shares of FHI Common Stock, together with any dividends or
distributions with respect thereto, being hereinafter referred to as the
"Exchange Fund") issuable pursuant to Sections 1.4 and 1.5(e), respectively, in
exchange for such shares of Company Common Stock.
(b) Exchange Procedures. As soon as reasonably practicable after
the Effective Time, the Exchange Agent shall mail to each holder of record of
shares of Company Common Stock immediately prior to the Effective Time whose
shares were converted into shares of FHI Common Stock pursuant to Section 1.4,
(i) a letter of transmittal (which shall specify that delivery shall be
effected, and risk of loss and title to the Company Certificates shall pass,
only upon delivery of the Company Certificates to the Exchange Agent, and which
shall be in such form and have such other provisions as FHI may reasonably
specify) and (ii) instructions for use in effecting the surrender of the
Company Certificates in exchange for certificates representing shares of FHI
Common Stock. Upon surrender of a Company Certificate for cancellation to the
Exchange Agent together with such letter of transmittal, duly executed, the
holder of such Company Certificate shall be entitled to receive in exchange
therefor a certificate representing that number of whole shares of FHI Common
Stock that such holder has the right to receive in respect of the Company
Certificate surrendered pursuant to the provisions of this Article I (after
taking into account all shares of Company Common Stock then held by such
holder), and the Company Certificate so surrendered shall forthwith be
cancelled. In the event of a transfer of ownership of shares of Company Common
Stock which is not registered in the transfer records of Company, a certificate
representing the proper number of shares of FHI Common Stock may be issued to a
transferee if the Company Certificate representing such Company Common Stock is
presented to the Exchange Agent, accompanied by all documents required to
evidence and effect such transfer and by evidence that any applicable stock
transfer taxes have been paid. Until surrendered as contemplated by this
Section 1.5, each Company Certificate shall be deemed at any time after the
Effective Time to represent only the shares of FHI Common Stock into which the
shares of Company Common Stock represented by such
Company Certificate have been converted as provided in this Article I and
the right to receive upon such surrender cash in lieu of any fractional
shares of FHI Common Stock as contemplated by this Section 1.5.
(c) Distributions with Respect to Unexchanged Shares; Voting. No
dividends or other distributions declared or made following the Effective Time
with respect to shares of FHI Common Stock with a record date after the
Effective Time shall be paid to the holder of any unsurrendered Company
Certificate with respect to the shares of FHI Common Stock represented thereby,
and no cash payment in lieu of fractional shares shall be paid to any such
holder pursuant to Section 1.5(e), until the holder of such Company Certificate
shall surrender such Company Certificate in accordance with this Article I.
Subject to the effect of applicable laws, following surrender of any such
Company Certificate, there shall be paid to the holder of the certificates
representing whole shares of FHI Common Stock issued in exchange therefor,
without interest, (A) at the time of such surrender, the amount of any cash
payable with respect to a fractional share of FHI Common Stock to which such
holder is entitled pursuant to Section 1.5(e) and the amount of dividends or
other distributions with a record date after the Effective Time theretofore
paid (but withheld pursuant to the immediately preceding sentence) with respect
to such whole shares of FHI Common Stock, and (B) at the appropriate payment
date, the amount of dividends or other distributions with a record date after
the Effective Time but prior to surrender and a payment date subsequent to
surrender payable with respect to such whole shares of FHI Common Stock.
(d) No Further Ownership Rights in Company Common Stock. All shares
of FHI Common Stock issued upon conversion of shares of Company Common Stock in
accordance with the terms hereof (including any cash paid pursuant to Section
1.5(c) or 1.5(e)) shall be deemed to have been issued in full satisfaction of
all rights pertaining to such shares of Company Common Stock, subject, however,
to FHI's obligation to pay any dividends or make any other distributions with a
record date prior to the Effective Time which may have been declared or made by
Company on such shares of Company Common Stock in accordance with the terms of
this Agreement on or prior to the Effective Time and which remain unpaid at the
Effective Time, and there shall be no further registration of transfers on the
stock transfer books of FHI of the shares of Company Common Stock which were
outstanding immediately prior to the Effective Time. If, after the Effective
Time, Company Certificates are presented to FHI for any reason, they shall be
cancelled and exchanged as provided herein.
(e) No Fractional Shares. (i) No certificates or scrip
representing fractional shares of FHI Common Stock shall be issued upon the
surrender for exchange of Company Certificates evidencing shares of Company
Common Stock, and such fractional share interests will not entitle the owner
thereof to vote or to any other rights of a shareholder of FHI.
(ii) Notwithstanding anything to the contrary contained in this
Agreement, each holder of shares of Company Common Stock exchanged pursuant to
this Article I who would otherwise have been entitled to receive a fraction of
a share of FHI Common Stock (after taking into account all shares of Company
Common Stock of such holder) shall receive, in lieu thereof, a cash payment
determined by multiplying the Valuation Price by the fraction of a share of FHI
Common Stock which such holder would otherwise be entitled to receive pursuant
to Section 1.4.
(f) Termination of Exchange Fund. Any portion of the Exchange Fund
which remains undistributed to the shareholders of Company for six months after
the Effective Time shall be delivered to FHI, upon demand, and any shareholders
of Company who have not theretofore complied with this Article I shall
thereafter look only to FHI for payment of their claim for shares of FHI Common
Stock, any cash in lieu of fractional shares of FHI Common Stock and any
dividends or distributions with respect to shares of FHI Common Stock.
(g) No Liability. Neither FHI, Sub, Company, the Surviving
Corporation nor the Exchange Agent shall be liable to any holder of Company
Certificates for shares of FHI Common Stock (or dividends or distributions with
respect thereto) or cash in lieu of fractional shares thereof delivered to a
public official pursuant to any applicable abandoned property, escheat or
similar law. If any certificates representing shares of Company Common Stock
shall not have been surrendered prior to five years after the Effective Time
(or immediately prior to such earlier date on which any shares of FHI Common
Stock, any cash in lieu of fractional shares of FHI Common Stock or any
dividends or distributions with respect to FHI Common Stock in respect of such
certificate would otherwise escheat to or become the property of any
Governmental Authority (as defined below)), any such shares, cash, dividends or
distributions in respect of such certificate shall, to the extent permitted by
applicable law, become the property of FHI, free and clear of all claims or
interest of any person previously entitled thereto.
ARTICLE II
THE CLOSING
2.1 Closing Date. Subject to Article VII, the closing (the
"Closing") of the transactions contemplated by this Agreement shall take place
on a date to which FHI, Sub and Company may agree (the "Closing Date");
provided, however, that in the absence of an agreement by the parties to the
contrary such Closing Date shall be the thirtieth business day after the later
to occur of satisfaction or waiver of the conditions to Closing set forth in
Article VI (excluding such conditions that by their terms cannot be satisfied
until the Closing Date).
2.2 Procedure. The Closing shall be held at the offices of FHI in
Honolulu, Hawaii, or at such other place as to which the parties hereto shall
agree. On the Closing Date and subject to the terms and conditions provided
herein, the Articles of Merger shall be filed with the Secretary of State of
the State of Washington.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF COMPANY
Except as otherwise disclosed to FHI in a schedule dated as of the
date hereof and delivered concurrently with the execution of this Agreement
(the "Company Schedule"), Company represents and warrants to FHI as follows:
3.1 Organization, Etc.
(a) Company is duly incorporated, validly existing and in good
standing under the laws of the State of Washington. Company has all requisite
power and authority to own, lease and operate its properties and to carry on
its businesses as now conducted and is qualified to do business as a foreign
corporation and in good standing in each jurisdiction in which such
qualification is necessary under applicable law, except to the extent that the
failure to be so qualified and in good standing would not, individually or in
the aggregate, have a Material Adverse Effect (as defined in Section 8.9).
(b) Company is a duly registered bank holding company under the Bank
Holding Company Act of 1956, as amended, and the rules and regulations
promulgated thereunder (the "BHC Act"). American National Bank, a national
banking association ("Company Bank"), is duly organized, validly existing and
in good standing under the National Bank Act, as amended. Company has no
subsidiaries other than Company Bank. Company Bank has no subsidiaries.
3.2 Non-Contravention; Binding Effect. Company has all requisite
corporate power and authority to enter into this Agreement and, subject to the
approval of this Agreement by the shareholders of Company, to consummate the
transactions contemplated hereby and to perform its obligations hereunder.
This Agreement has been duly and validly authorized, executed and delivered by
Company and constitutes the valid and legally binding obligation of Company,
enforceable against Company in accordance with its terms, except as may be
limited by bankruptcy, insolvency, moratorium, reorganization or similar laws
affecting the rights of creditors generally or general equitable principles.
Neither the execution and delivery of this Agreement by Company, nor the
consummation by it of the transactions contemplated hereby, nor compliance by
it with any of the provisions hereof will (i) conflict with or result in a
breach of any provision of Company's articles of incorporation or by-laws or
the charter or organizational documents of any of its subsidiaries; or (ii)
subject to obtaining the approvals of third parties referred to in Section 3.3,
conflict with or constitute or result in the breach of any term, condition or
provision of, or constitute a default under, or give rise to any right of
termination, cancellation or acceleration with respect to, or result in the
loss of any material benefit under, or the creation of any lien, charge or
encumbrance upon any property or assets of Company or any of its subsidiaries
pursuant to, any note, bond, mortgage, indenture, license, agreement, lease or
other instrument, contract or obligation to which Company or any of its
subsidiaries is a party or by which any of their properties or assets may be
bound, except for such breaches, defaults, rights of termination, cancellation
or acceleration, losses of benefits, liens, charges or encumbrances as would
not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect; or (iii) subject to obtaining the requisite Regulatory
Approvals (as defined in Section 5.1), violate any order, writ, injunction,
decree, permit, statute, law, ordinance, rule or regulation applicable to
Company or any of its subsidiaries or any of their respective properties or
assets.
3.3 No Consent. Except as set forth in Section 3.3 of the Company
Schedule, no consents, approvals, orders, resolutions or forebearances, by or
from, and no registrations, declarations or filings with, any governmental or
regulatory agency, authority, corporation, board, commission, department or
other governmental instrumentality (a "Governmental Authority") or any other
third party, are required in order for Company or its subsidiaries to enter
into this Agreement, to consummate the transactions contemplated hereby or to
perform their obligations hereunder.
3.4 Compliance with Laws.
(a) Company and each of its subsidiaries has conducted its business
in compliance with all statutes, laws, rules, regulations, ordinances, permits,
reporting and licensing requirements and orders applicable to its business or
properties or any of its employees, the breach or violation of which could,
individually or in the aggregate, have a Material Adverse Effect. Company
holds all permits, authorizations, licenses, variances, exemptions, orders and
approvals of all Governmental Authorities which are material to the business of
Company and its subsidiaries taken as a whole, and all such permits,
authorizations, licenses, variances, exemptions, orders and approvals are in
full force and effect and, to the best of its knowledge, no suspension or
cancellation of any of them is pending or threatened.
(b) Neither Company nor any subsidiary thereof has received any
notification from any Governmental Authority asserting that Company or such
subsidiary is not in compliance with any of the statutes, regulations or
ordinances that such Governmental Authority enforces, except for such
noncompliance as would not reasonably be expected to have, individually or in
aggregate, a Material Adverse Effect. Neither Company nor any subsidiary
thereof is party to or the subject of any supervisory agreement, memorandum of
understanding, cease-and-desist order, consent decree, assistance agreement or
any similar agreement or arrangement with any Governmental Authority with
respect to its assets, capital, operations or business (nor has Company or any
of its subsidiaries adopted any board resolutions or made any written
commitments with respect to any of the foregoing at the request of any
Governmental Authority), and neither Company nor any of its subsidiaries has
been advised by any Governmental Authority that it contemplates issuing or
requesting (or is considering the appropriateness of issuing or requesting) any
such supervisory agreement, memorandum of understanding, cease-and-desist
order, consent decree, assistance agreement or similar agreement or arrangement
or any such board resolutions or written commitments. Except for routine
examinations by federal or state Governmental Authorities charged with the
supervision or regulation of bank holding companies and national banking
associations, to the best knowledge of Company, no investigation by any
Governmental Authority is pending or threatened against Company or any
subsidiary or, in the reasonable judgment of Company, probable of assertion
after the date hereof which would reasonably be expected to have a Material
Adverse Effect.
3.5 Capitalization.
(a) As of the date hereof, the authorized capital of Company
consists of 100,000 shares of preferred stock, no par value, and 500,000 shares
of Company Common Stock. As of the date hereof, no shares of preferred stock
of Company are issued and outstanding, 149,824 shares of Company Common Stock
are issued and outstanding and 14,900 shares of Company Common Stock are
reserved for issuance pursuant to Company Stock Options, of which Company Stock
Options 8,900 have been granted and are outstanding on the date hereof. As of
the date hereof, no shares of Company Common Stock are owned beneficially or of
record by Company as treasury stock or by its subsidiaries.
(b) As of the date hereof, no bonds, debentures, notes or other
indebtedness having the right to vote on any matters on which shareholders may
vote ("Voting Debt") are issued or outstanding with respect to Company.
(c) All of the issued and outstanding shares of Company Common Stock
have been duly and validly authorized and issued, are fully paid and
nonassessable and were not issued in violation of any preemptive rights of
shareholders of Company. Except as set forth in Section 3.5(a) or in Section
3.5 of the Company Schedule, there are no outstanding subscriptions, options,
rights, warrants, convertible securities or other agreements or commitments
obligating Company to issue, transfer from the treasury, deliver or sell any
additional shares of Company's capital stock or Voting Debt or to grant, extend
or enter into any such option, right, warrant, convertible security, commitment
or agreement, and no unissued shares of Company Common Stock are subject to any
preemptive rights of shareholders of Company. There are no outstanding
contractual obligations of Company to repurchase, redeem or otherwise acquire
any outstanding shares of capital stock of or other ownership interest in
Company. Except as set forth in Section 3.5 of the Company Schedule, as of the
date of this Agreement, no person held of record, or to the best knowledge of
Company, beneficially, 5% or more of the outstanding shares of Company Common
Stock.
3.6 Subsidiaries. Section 3.6 of the Company Schedule shows all of
the authorized, issued and outstanding shares of capital stock of, and other
equity and ownership interests in, Company Bank. Except as shown in Section
3.6 of the Company Schedule, Company owns directly or indirectly all of the
outstanding capital stock of, and all other equity or ownership interests in,
Company Bank, free and clear of all liens, charges and encumbrances, and no
Voting Debt of Company Bank is outstanding. There are no outstanding
subscriptions, options, rights, warrants, convertible securities, or other
agreements,
commitments or rights to subscribe for or purchase from Company, or
any plans, contracts or commitments providing for the issuance of, or the
granting or extending of rights to acquire, (i) any capital stock of or other
ownership interest in, or Voting Debt of Company Bank, or (ii) any securities,
options, rights, warrants, convertible securities or other such security
convertible into or exchangeable for any capital stock of or other ownership
interest in or Voting Debt of Company Bank. There are no outstanding
contractual obligations of Company to repurchase, redeem or otherwise acquire
any outstanding shares of capital stock of or other ownership interest in
Company Bank. All of the outstanding shares of the capital stock of Company
Bank have been duly and validly issued, are fully paid and nonassessable and
were not issued in violation of any preemptive rights. Company has no direct
or indirect equity interest in any other firm, corporation, savings
association, partnership, joint venture or business enterprise other than as
are listed in Section 3.6 of the Company Schedule.
3.7 Charter Documents; Management.
(a) The copies of the articles of incorporation and by-laws of
Company, and the charter and by-laws or other organizational documents of
Company Bank (and any amendments thereto), delivered to FHI prior to the date
of this Agreement are true and complete copies, and such articles of
incorporation, charters, by-laws and other organizational documents are in full
force and effect.
(b) The name and title or position of each officer or director as of
the date hereof of Company and Company Bank are disclosed in Section 3.7(b) of
the Company Schedule.
3.8 Financial Statements and Reports.
(a) Company has previously furnished to FHI true and complete copies
of the audited consolidated balance sheets of Company and its subsidiaries as
of December 31, 1994 and 1995 and the related statements of income, changes in
stockholders' equity and cash flows for the fiscal years ended December 31,
1993 through 1995 inclusive, accompanied by the audit report of Knight Vale and
Gregory Inc., P.S., independent public accountants of Company.
(b) All of the financial statements of Company referred to above
were (and in the case of financial statements provided to FHI after the date
hereof pursuant to Section 5.2(b) will be) prepared in accordance with GAAP
applied on a consistent basis for the periods involved and fairly present (or
will fairly present) the financial condition of Company and its subsidiaries as
of the dates thereof and the consolidated results of their
operations, changes in stockholders' equity and cash flows for the periods
then ended, subject in the case of interim statements to normal recurring
year-end adjustments none of which are expected to be material. Company and
its subsidiaries have no liabilities or obligations of any nature (absolute,
accrued, contingent or otherwise) that are not fully reflected or reserved
against in the balance sheet as of December 31, 1995 included in such
financial statements, except for liabilities and obligations disclosed in
Section 3.8(b) of the Company Schedule or incurred after the date of this
Agreement in the ordinary course of business consistent with past practice
and not in violation of this Agreement.
(c) No report or other document filed by Company or any subsidiary
since January 1, 1992 with the Office of the Comptroller of the Currency
("OCC"), the Board of Governors of the Federal Reserve System (the "Federal
Reserve Board") or the Federal Deposit Insurance Corporation (the "FDIC") under
applicable federal, state, territorial or foreign laws or regulations, as of
the date thereof, contained or, in the case of filings made after the date
hereof, will contain any untrue statement of a material fact or omitted, or in
the case of filings made after the date hereof will omit, to state a material
fact required to be stated therein, or necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Since January 1, 1992 each of Company and its subsidiaries has
filed and after the date of this Agreement will file in a timely manner all
required filings with the OCC, the Federal Reserve Board, the FDIC and all
other appropriate Governmental Authorities, and all such filings complied and
will comply as to form in all material respects with the regulatory
requirements applicable thereto.
3.9 Properties.
(a) Company or a subsidiary thereof has good and marketable title to
all properties and assets owned and used in the business of Company and its
subsidiaries, including the real properties reflected in Company's audited
consolidated balance sheet for the year ended December 31, 1995 (except to the
extent any such owned properties or assets have been disposed of since such
date in the ordinary course of business and such dispositions, individually or
in the aggregate, are not material), free and clear of all liens, claims,
charges, security interests or other encumbrances, other than liens, claims,
charges, security interests and encumbrances which do not individually or in
the aggregate materially and adversely affect the use and enjoyment of the
properties or assets subject thereto or business operations at such properties.
(b) Section 3.9(b) of the Company Schedule lists all of the offices
and branches maintained and operated by Company and its subsidiaries, including
the address or description thereof and whether it is held in fee or leasehold.
Except as shown in Section 3.9(b) of the Company Schedule, neither Company nor
any of its subsidiaries maintains any other office or conducts business at any
other location.
(c) All properties and assets held by Company or a subsidiary
thereof under lease are held under valid instruments, enforceable in accordance
with their terms, except as may be limited by bankruptcy, insolvency,
moratorium, reorganization or similar laws affecting the rights of creditors
generally or general equitable principles. As of the date hereof, there is no
default (or event or circumstance which, with the giving of notice or lapse of
time, would constitute such a default) by the lessee or, to the knowledge of
Company, the lessor under any such lease.
(d) Company and its subsidiaries are insured with reputable
insurers, in such amounts as have been disclosed to FHI and against all risks
normally insured against by corporations or organizations in similar lines of
business, and all insurance policies and bonds maintained by Company and each
of its subsidiaries as of the date hereof are listed in Section 3.9(d) of the
Company Schedule and are in full force and effect. As of the date hereof,
neither Company nor any of its subsidiaries has received any notice of
cancellation or material amendment of any insurance policy or bond or is in
default under any such policy or bond, no coverage thereunder is being
disputed, and all claims thereunder have been filed in timely fashion.
(e) Neither Company nor any subsidiary has outstanding any
commitment for capital expenditures, except as disclosed in Section 3.9(e) of
the Company Schedule.
3.10 Absence of Certain Changes. Except as set forth in Section
3.10 of the Company Schedule, since December 31, 1995, Company and its
subsidiaries have conducted their businesses in the ordinary course, consistent
with past practice (except as expressly required to perform their obligations
under this Agreement), and there has not been since December 31, 1995:
(a) Any change or event that has had or could reasonably be expected
to have, together with all other such changes and events, a Material Adverse
Effect; or
(b) Any amendment to the articles of incorporation or by-laws or
organizational documents of Company or of any of its subsidiaries; or
(c) Any declaration, setting aside or payment of any dividend
(whether in cash, stock or other property) or any other distribution in respect
of the capital stock of Company or its subsidiaries (other than dividends paid
on the capital stock of wholly-owned subsidiaries of Company); or
(d) Any issuance, reissuance, sale or acquisition of (or agreement
to issue, reissue, sell or acquire) shares of capital stock, other equity
securities or rights, options or warrants to acquire any such shares of stock
or other equity securities of Company or any of its subsidiaries; or
(e) Any subdivision, combination, aggregation or reclassification of
any shares of capital stock or redemption or repurchase of any shares of such
capital stock of Company or any of its subsidiaries; or
(f) Any merger or consolidation (or agreement to merge or
consolidate) with any other corporation, or conveyance to any other person,
firm or corporation, or encumbrance of (or agreement to convey or encumber) a
material part of Company's assets or the assets of any of its subsidiaries, or
the acquisition (or agreement to acquire) of all or substantially all of the
assets of another person, firm or corporation; or
(g) Entry into any material contract, arrangement or commitment
except in the ordinary course of the respective businesses of Company and its
subsidiaries consistent with their past practices; or
(h) Implementation of any pension, retirement, profit sharing,
bonus, welfare benefit or similar plan or arrangement or the material amendment
of any existing plan or arrangement, other than as required by law; or
(i) Incurrence of any indebtedness for borrowed money in excess of
$100,000, whether or not in the ordinary course of business, or any assumption,
guarantee or endorsement of any obligation of any other individual or entity,
except, in any such case, for deposit liabilities and assumptions, guarantees,
letters of credit, endorsements, Federal Home Loan Bank borrowings, and Fed
Funds borrowings incurred or entered into by Company Bank in the ordinary
course of its banking business consistent with past practice; or
(j) Any change by Company or its subsidiaries in accounting
principles or methods, except as required by the Financial Accounting Standards
Board ("FASB") or regulations promulgated by the OCC with respect to financial
statements filed with it; or
(k) Any increase in compensation payable or any agreement to
increase compensation payable by Company or any of its subsidiaries to any of
their respective directors, officers, employees or agents, other than normal
cost-of-living and regularly scheduled increases to non-executive employees of
Company and its subsidiaries; or
(l) Entry into any agreement to (i) do any of the foregoing other
than as expressly provided herein or (ii) take any action which, if taken prior
to the date hereof, would have made any representation or warranty contained in
this Article III untrue or incorrect.
3.11 Material Contracts.
(a) Except as disclosed in Section 3.11 of the Company Schedule,
neither Company nor any of its subsidiaries is a party to any oral or written
(i) agreement not terminable on 60 days' or less notice involving the payment
of more than $100,000 per annum, (ii) joint venture agreement, or (iii)
noncompetition or similar agreement that restricts Company or its subsidiaries
from engaging in a line of business.
(b) Neither Company nor any subsidiary is in default under any
contract, agreement, indenture, mortgage, deed of trust, loan instrument,
commitment, arrangement, lease, insurance policy or other instrument to which
it is a party or by which its respective properties or assets may be bound or
subject or under which it or its respective business, properties or assets
receive benefits, except for any such defaults which would not, individually or
in the aggregate for all such defaults, have a Material Adverse Effect, and
there has not occurred any event that with the lapse of time or the giving of
notice or both would constitute such a default.
3.12 Litigation. There are no suits, claims, actions or proceedings
against or affecting Company or any of its subsidiaries pending or, to the best
of knowledge of Company, threatened, or, in the reasonable judgment of Company,
probable of assertion, which could reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect, or which could restrict Company
or any subsidiary thereof from engaging in a line of business, nor is there any
judgment, decree, injunction, rule or order of any Governmental Authority or
arbitrator outstanding against Company or any subsidiary which could have a
Material Adverse Effect or which could restrict Company or any subsidiary from
engaging in a line of business.
3.13 Regulatory Applications. The information relating to Company
and its subsidiaries provided by Company for inclusion in any applications
filed for Regulatory Approvals, and in the proxy statement relating to the
approval of this Agreement and the Merger by Company's shareholders and any
amendment or supplement thereto (the "Proxy Statement"), shall comply in all
material respects with relevant laws and regulations and will not contain any
untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not
misleading.
3.14 Taxes.
(a) Definitions. For purposes of this Section 3.14, the following
definitions shall apply:
(i) The term "Group" shall mean, individually and collectively,
Company and each other corporation that is a member of the affiliated
group of corporations within the meaning of Section 1504 of the Internal
Revenue Code of 1986, as amended (the "Code"), of which Company is the
common parent.
(ii) The term "Taxes" shall mean all taxes, however denominated,
including any interest, penalties or other additions that may become
payable in respect thereof, imposed by any federal, territorial, state,
local or foreign government or any agency or political subdivision of any
such government, which taxes shall include, without limiting the
generality of the foregoing, all income or profits taxes (including, but
not limited to, federal income taxes and state franchise and income
taxes), payroll and employee withholding taxes, unemployment insurance
taxes and social security taxes, sales and use taxes, ad valorem taxes,
excise taxes, franchise taxes, gross receipts taxes, business license
taxes, occupation taxes, real and personal property taxes, stamp taxes,
environmental taxes, transfer taxes, workers' compensation, Pension
Benefit Guaranty Corporation (the "PBGC") premiums and other governmental
charges, backup withholding taxes, and other obligations of the same or of
a similar nature to any of the foregoing, which the Group, Company or any
of its subsidiaries is required to pay, withhold or collect.
(iii) The term "Returns" shall mean all reports, estimates,
declarations of estimated tax, information statements and returns relating
to, or required to be filed in connection with, any Taxes.
(b) Company and each of its subsidiaries is, has been and will be a
member of the Group for all taxable periods before the Closing Date. The Group
has timely filed all Returns required to be filed, and the information
contained in each such Return is complete and accurate, except in such respects
as would not have a Material Adverse Effect.
(c) The Group has paid all Taxes required to be paid in respect of
the periods covered by such Returns, and the Group has no liability for such
Taxes (and, to the best knowledge of Company, there is no potential liability
in respect of deductions, costs or other allowances taken for federal income
tax purposes likely to be disallowed in any audit by the Internal Revenue
Service) in excess of the amounts so paid or reserves so established.
(d) The Group is not delinquent in the payment of any Taxes, and it
has not requested any extension of time within which to file any Returns that
have not since been filed, with the exception of the 1995 consolidated federal
income tax return Form 1120, and no deficiencies for any Taxes have been
claimed, proposed or assessed. There are no outstanding extensions of time for
the assessment of any Taxes payable by the Group.
(e) There are no pending or, to the best of Company's knowledge,
threatened, tax audits, investigations, or claims for or relating to any
liability in respect of Taxes, except any such audits, investigations or claims
that, individually or in the aggregate, could not reasonably be expected to
have a Material Adverse Effect, and there are no matters under discussion with
any taxing authorities with respect to Taxes that are likely to result in a tax
liability, except such as could not reasonably be expected to have a Material
Adverse Effect.
(f) As of the date hereof, the Group's federal income tax Returns
have been audited and closed by the Internal Revenue Service or the applicable
statute of limitations has expired for all taxable periods through the year
ended December 31, 1991 and its State of Washington franchise and income tax
Returns have been audited and closed by the Department of Revenue of the State
of Washington or the applicable statute of limitations has expired for all
taxable periods through the period ended December 31, 1992.
(g) The Group is not a party to any safe harbor lease within the
meaning of Section 168(f)(8) of the Code, as in effect prior to amendment by
the Tax Equity and Fiscal Responsibility Act of 1982. No member of the Group
is a "consenting corporation" under Section 341(f) of the Code.
3.15 Employee Benefit Plans; ERISA.
(a) Except as set forth in Section 3.15(a) of the Company Schedule
and as of the date hereof, neither Company nor any subsidiary is a party to or
has or could have any liability or obligation with respect to (i) any "employee
benefit plan" within the meaning of Section 3(3) of the Employee Retirement
Income Security Act of 1974, as amended ("ERISA"), (ii) any profit sharing,
pension, deferred compensation, bonus, stock option, stock purchase, severance,
retainer, consulting, health, welfare or incentive plan or agreement, including
any post-employment benefits, (iii) any material plan or policy providing for
"fringe benefits" to its employees, including but not limited to vacation, paid
holidays, personal leave, employee discount, educational benefit or similar
programs or (iv) any employment agreement (individually a "Benefit Plan", and
collectively the "Benefit Plans").
(b) Company has heretofore delivered to FHI correct and complete
copies of (A) the Benefit Plans, (B) any employment, consulting or termination
agreements with respect to current or former employees of Company or any
subsidiary to the extent any liability or obligation remains thereunder, (C)
the two most recent Internal Revenue Service determination letters relating to
each of its employee pension benefit plans, as defined in Section 3(2) of ERISA
(the "Employee Pension Benefit Plans") for which such letters of determination
were obtained, (D) to the extent required to be filed, the two most recent
Annual Reports (Form 5500 Series) and accompanying schedules of each Benefit
Plan, as filed with the Internal Revenue Service, (E) any summary plan
descriptions relating to any Benefit Plan, (F) if applicable, the most recent
audited financial statements of each of its Employee Pension Benefit Plans and
(G) the two most recent actuarial valuation reports for each of its Employee
Pension Benefit Plans for which such reports were prepared.
(c) Company and each subsidiary has received, with respect to each
of the Employee Pension Benefit Plans which is intended to qualify under
Section 401(a) of the Code, a favorable determination letter issued by the
Internal Revenue Service, and no events, actions or failures to act have
occurred which would adversely affect the qualification of any such Employee
Pension Benefit Plan. Neither Company, any subsidiary nor any entity which is
part of a group which includes Company or any subsidiary and which is treated
as a single employer under Section 414 of the Code (a "Controlled Group
Member") contributes to a "multiemployer plan", as defined in Section
4001(a)(3) of ERISA, or had a complete or partial withdrawal from any such
multiemployer plan, the liability for which remains unsatisfied. Each of the
Benefit Plans has been administered in all material
respects in accordance with its terms, the requirements of ERISA and any other
applicable law.
(d) All reports and information required to be filed with the United
States Department of Labor, Internal Revenue Service or PBGC or distributed to
plan participants and their beneficiaries, which if not timely filed or
distributed would result in any liability to Company or any subsidiary with
respect to any Benefit Plan, have been timely filed or distributed. With
respect to each Benefit Plan for which an Annual Report had been filed, no
change has occurred with respect to the matters covered by the most recent
Annual Report since the date thereof which would result in any liability to
Company or any subsidiary.
(e) None of the Employee Pension Benefit Plans (or any pension plan
maintained by a Controlled Group Member) which is subject to Title IV of ERISA
have (A) completely or partially terminated or (B) been the subject of a
"reportable event" as defined in Section 4043 of ERISA, if any such event would
result in any liability to Company or any subsidiary.
(f) No proceedings by the PBGC to terminate pursuant to Subtitle C
of Title IV of ERISA any Employee Pension Benefit Plan of Company (or any
pension plan maintained by a Controlled Group Member) have been instituted or
threatened. No material liability under Title IV of ERISA has been incurred by
Company or any subsidiary with respect to an Employee Pension Benefit Plan (or
any pension plan maintained by a Controlled Group Member). None of the
Employee Pension Benefit Plans (or any pension plan of a Controlled Group
Member) which is a defined benefit pension plan has incurred any "accumulated
funding deficiency" (whether or not waived), as that term is defined in Section
412 of the Code, and the fair market value of the assets held to fund each such
plan equals or exceeds the actuarial present value (based on the actuarial
assumptions used by the actuary of the plan for purposes of determining the
contributions for such plan) of all accrued benefits, both vested and
nonvested, under such plan.
(g) All contributions for all periods ending prior to the Closing
Date (including periods from the first day of the current plan year to the
Closing Date) will be made prior to the Closing Date by Company or one of its
subsidiaries, as applicable, in accordance with past practice.
(h) There have been no "prohibited transactions" (as such term is
defined in Section 4975 of the Code or in Part 4 of Subtitle B of Title I of
ERISA) with respect to any Benefit Plan as to which Company or any subsidiary
may have any liability. No penalty or tax for which Company or any of its
subsidiaries may be liable has been imposed under Section 502(i) of ERISA or
Section 4975 of the Code.
(i) There are no pending, or to the best knowledge of Company
threatened, claims by or on behalf of any Benefit Plan, by any employee or
beneficiary covered under any such Benefit Plan which allege a breach of
fiduciary duties or violations of other applicable state or federal law which
may result in liability on the part of Company or any subsidiary or result in
any decrease in the assets of any Benefit Plan under ERISA or any other law,
nor, to Company's best knowledge, is there any basis for any such claim.
Company will notify FHI in writing of any such threatened or pending claims
arising after the date hereof but before the Effective Time.
(j) Neither Company nor any subsidiary has any obligation to
provide, or liability with respect to, any post-retirement benefits for any
current or former employee under any "welfare benefit plan" as defined in
Section 3(1) of ERISA.
(k) All expenses and liabilities relating to all of the Benefit
Plans described in Section 3.16(k) of the Company Schedule have been, and will
on the Closing Date be, fully and properly accrued on Company's books and
records, to the extent required by GAAP.
3.16 Labor Relations. Neither Company nor any of its subsidiaries
is a party to any collective bargaining agreement. Since December 31, 1990, no
material labor dispute, strike or other work stoppage has occurred, is
continuing or, to the knowledge of Company, has been threatened with respect to
Company or any of its subsidiaries, and, to the knowledge of Company, no union
organizing, certification or election activities have taken place with respect
to Company or any of its subsidiaries.
3.17 Employment and Similar Agreements; Obligations Upon Change in
Control. Except as disclosed in Section 3.17 of the Company Schedule, there
are no employment, consulting, severance or indemnification agreements or
understandings of legal effect ("Employee Agreements") between Company or any
of its subsidiaries, on the one hand, and any director, officer or employee of
Company or of any of its subsidiaries or any other party, on the other hand.
Except as set forth in Section 3.17 of the Company Schedule, there are no such
Employee Agreements (i) under which any of the transactions contemplated by
this Agreement will require any payment by Company or any of its subsidiaries,
or by FHI, Sub or Surviving Corporation, to any director, officer or employee
of Company or of any of its subsidiaries, or any other party, or (ii) under
which there will occur any acceleration or change in the award, grant, vesting
or determination of options, warrants, rights, severance payments, or other
contingent obligations of any nature whatsoever of Company or any of its
subsidiaries in favor of any such parties, or under which the value of any
benefits will be calculated on
the basis of any of the transactions contemplated by this Agreement.
3.18 Broker's and Finder's Fees. Except for payments to Ragen
MacKenzie Incorporated, which has been engaged by Company as its financial
advisor and investment banker (pursuant to an agreement, a copy of which has
been delivered to FHI), neither Company nor any of its subsidiaries has any
liability to any broker, finder or similar agent, nor has any of them agreed to
pay any brokerage fee, finder's fee or commission with respect hereto or to the
transactions contemplated hereby.
3.19 Hazardous Materials.
(a) Except as shown in Section 3.19 of the Company Schedule,
Hazardous Materials have not been deposited or disposed of in, on or under, or
released, emitted or discharged from, any of Company's or any of its
subsidiaries' properties during the time when Company or such subsidiary owned
the property. Except as shown in Section 3.19 of the Company Schedule, neither
Company nor any of its subsidiaries has any knowledge or information that any
prior owners, occupants or operators of any such properties ever deposited,
disposed of, or allowed to be deposited or disposed of in, on or under or
released, emitted or discharged from, such properties, any Hazardous Material,
or that any prior or present owners, occupants or operators of any properties
in which any of Company or Company's subsidiaries hold a security interest,
mortgage or other lien or interest, deposited or disposed of in, on or under or
handled or processed on, or released, emitted or discharged from, such
properties, any Hazardous Material. "Hazardous Material" shall mean any
substance, chemical, waste or other material which is listed, defined or
otherwise identified as hazardous, toxic or dangerous under any applicable law,
regulation or order of any Governmental Authority, as well as any petroleum,
petroleum product or by-product, crude oil, natural gas, natural gas liquids,
liquefied natural gas, or synthetic gas usable for fuel, and "source," "special
nuclear," and "by-product" material as defined in the Atomic Energy Act of
1985, 42 U.S.C. Section 3011 et seq.
(b) Neither Company nor any of its subsidiaries nor, to the best
knowledge of Company, any of its or their borrowers is in violation (either
directly, including as a successor-in-interest in connection with the
realization of properties serving as collateral, or indirectly, as a collateral
interest holder) of any judgment, decree, order, law, license, rule or
regulation pertaining to environmental laws, except to the extent that such
violations, individually or in the aggregate, could not be reasonably expected
to have a Material Adverse Effect, nor has Company or any of its subsidiaries
or, to the best knowledge of Company, any of its or their borrowers, received
notice from any
Governmental Authority of any such violation or of any remedial
investigation or action which could reasonably be expected to have a Material
Adverse Effect.
3.20 Damage to Mortgaged Properties. Except as set forth in
Section 3.20 of the Company Schedule, none of the properties securing
outstanding loans held or serviced by Company or any of its subsidiaries has
suffered material damage or casualty loss not covered in full by an insurance
policy written by a reputable insurer whose claims paying capacity has not been
impaired, nor has Company or any of its subsidiaries funded any loan
commitments or granted any forebearances with respect to loans secured by
properties that are not fully insured against casualty losses on customary
terms by a reputable insurer whose claims paying capacity has not been
impaired. Except as set forth in Section 3.20 of the Company Schedule, all
outstanding single-family residential mortgage loans originated or serviced by
Company are insured in amounts and by insurers that meet the requirements of
the Federal Home Loan Mortgage Corporation or the Federal National Mortgage
Association for resale in secondary market transactions, and none of the
mortgagors for such loans has advised Company or any of its subsidiaries that
the hazard or casualty insurance policy on such mortgaged property has not been
or will not be renewed and that such mortgagor is unable to obtain a substitute
or replacement policy in accordance with the terms of such mortgage.
3.21 Shareholder Approval. The affirmative vote of the holders of
two-thirds of the outstanding shares of Company Common Stock is required to
approve this Agreement and approve the Merger. No other vote of the
shareholders of Company is required by law, the articles of incorporation or
by-laws of Company or otherwise to adopt this Agreement and approve the Merger
and the other transactions contemplated hereby.
3.22 Deposit Accounts. The deposits of Company Bank are insured by
the Bank Insurance Fund ("BIF") of the FDIC in accordance with the provisions
of the Federal Deposit Insurance Act, as amended (the "FDI Act"). Company Bank
has paid all regular premiums and special assessments and filed all reports
required under the FDI Act and its predecessor statutes, except where any such
failures to do so, alone or in the aggregate, could not reasonably be expected
to have a Material Adverse Effect.
3.23 Trademarks, Etc. Each of Company and its subsidiaries owns or
possesses the right, free of the claims of any third party, to use all
trademarks, service marks, trade names, copyrights, patents and licenses
currently used by it in the conduct of its business, except where the failure
to so own or possess the right would not, individually or in the aggregate,
cause a Material Adverse Effect. To the knowledge of Company, no product or
service offered by Company or its subsidiaries infringes any rights of any
other person, and neither Company nor any subsidiary has received written or
oral notice of any claim of such infringement.
3.24 Disclosure. No written statement, certificate, schedule, list
or other written information furnished by or on behalf of Company or any
subsidiary to FHI prior to the date hereof contains any untrue statement of a
material fact or omits to state a material fact necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF FHI AND SUB
Except as otherwise disclosed to Company in a schedule dated as of
the date hereof and delivered concurrently with the execution of this Agreement
(the "FHI Schedule"), each of FHI and Sub represents and warrants to Company as
follows:
4.1 Organization, Etc.
(a) Each of FHI and its subsidiaries, including Sub, is duly
incorporated or organized, validly existing and in good standing under the
jurisdiction of its incorporation or organization. Each of FHI and its
subsidiaries, including Sub, has all requisite power and authority to own,
lease and operate its properties and to carry on its businesses as now
conducted and is qualified to do business as a foreign corporation and in good
standing in each jurisdiction in which such qualification is necessary under
applicable law, except to the extent that the failure to be so qualified and in
good standing would not, individually or in the aggregate, have a Material
Adverse Effect.
(b) FHI is a duly registered bank holding company pursuant to the
BHC Act and a duly registered savings and loan holding company under Section 10
of the Home Owners' Loan Act, as amended. First Hawaiian Bank, a wholly-owned
subsidiary of FHI, is a banking corporation duly incorporated, validly
existing, and in good standing under the laws of the State of Hawaii. Pioneer
Federal Savings Bank ("Pioneer"), a wholly-owned subsidiary of FHI, is a
federally chartered savings bank duly organized, validly existing and in good
standing under the laws of the United States. The deposit accounts of First
Hawaiian Bank and Pioneer are insured by the BIF and the Savings Association
Insurance Fund of the FDIC, respectively, to the fullest extent permitted under
applicable law.
4.2 Non-Contravention; Binding Effect. Each of FHI and Sub has all
requisite corporate power and authority to enter into this Agreement and to
consummate the transactions contemplated hereby and to perform its obligations
hereunder. This Agreement has been duly and validly authorized, executed and
delivered by each of FHI and Sub and constitutes the valid and legally binding
obligation of each of FHI and Sub, enforceable against each of FHI and Sub in
accordance with its terms, except as may be limited by bankruptcy, insolvency,
moratorium, reorganization or similar laws affecting the rights of creditors
generally, or general equitable principles. Neither the execution and delivery
of this Agreement nor the consummation by each of FHI and Sub of the
transactions contemplated hereby, nor compliance by each of FHI and Sub with
any of the provisions hereof will (i) conflict with or result in a breach of
any provision of FHI's or Sub's articles of incorporation or by-laws or the
charter or organization documents of any of FHI's subsidiaries, or (ii) subject
to obtaining the approvals of third parties referred to in Section 4.3,
conflict with or constitute or result in the breach of any term, condition or
provision of, or constitute a default under, or give rise to any right of
termination, cancellation or acceleration with respect to, or result in the
loss of any material benefit under, or the creation of any lien, charge or
encumbrance upon any property or assets each of FHI or any of its subsidiaries,
including Sub, pursuant to, any note, bond, mortgage or indenture, or license,
agreement, lease or other instrument or obligation to which FHI or any of its
subsidiaries, including Sub, is a party or by which any of their properties or
assets may be bound, except for such breaches, defaults, rights of termination,
cancellation or acceleration or losses of benefit and such liens, charges and
encumbrances as would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect, or (iii) subject to obtaining the
requisite Regulatory Approvals (as defined in Section 5.1), violate any order,
writ, injunction, decree, statute, rule or regulation applicable to FHI or any
of its subsidiaries, including Sub, or any of their respective properties or
assets.
4.3 No Consent. Except as set forth in Section 4.3 of the FHI
Schedule, no consents, approvals, orders, resolutions or forebearances by or
from any Governmental Authority or any other third party are required in order
for FHI or its subsidiaries, including Sub, to enter into this Agreement, to
consummate the transactions contemplated hereby and to perform their
obligations hereunder.
4.4 Compliance with Laws.
(a) Each of FHI and its subsidiaries has conducted its business in
compliance with all statutes, laws, rules, regulations, ordinances, permits,
reporting and licensing requirements and orders applicable to its business or
properties or any of its employees, the breach or violation of which could,
individually or in the aggregate, have a Material Adverse Effect. Each of FHI
and its subsidiaries holds all permits, authorizations, licenses, variances,
exemptions, orders and approvals of all Governmental Authorities which are
material to the business of FHI and its subsidiaries taken as a whole, and all
such permits, authorizations, licenses, variances, exemptions, orders and
approvals are in full force and effect and, to the best of FHI's knowledge, no
suspension or cancellation of any of them is pending or threatened.
(b) Neither FHI nor any subsidiary thereof has received any
notification from any Governmental Authority asserting that FHI or such
subsidiary is not in compliance with any of the statutes, regulations or
ordinances that such Governmental Authority enforces, except for such
noncompliance as would not reasonably be expected to have, individually or in
aggregate, a Material Adverse Effect. Except as set forth in Section 4.4 of
the FHI Schedule, neither FHI nor any subsidiary thereof is party to or the
subject of any supervisory agreement, memorandum of understanding,
cease-and-desist order, consent decree, assistance agreement or any similar
agreement or arrangement with any Governmental Authority with respect to its
assets, capital, operations or business (nor has FHI or any of its subsidiaries
adopted any board resolutions or made any written commitments with respect to
any of the foregoing at the request of any Governmental Authority), and neither
FHI nor any of its subsidiaries has been advised by any Governmental Authority
that it contemplates issuing or requesting (or is considering the
appropriateness of issuing or requesting) any such supervisory agreement,
memorandum of understanding, cease-and-desist order, consent decree, assistance
agreement or similar agreement or arrangement or any such board resolutions or
written commitments. Except for routine examinations by federal or state
Governmental Authorities charged with the supervision or regulation of bank
holding companies, banks and savings associations, to the best knowledge of
FHI, no investigation by any Governmental Authority is pending or threatened
against FHI or any subsidiary or, in the reasonable judgment of FHI, probable
of assertion after the date hereof which would reasonably be expected to have a
Material Adverse Effect.
4.5 Capitalization.
(a) As of the date hereof, the authorized capital of FHI consists of
100,000,000 shares of FHI Common Stock. As of the date hereof, 31,117,863
shares of FHI Common Stock are issued and outstanding and 997,825 shares of FHI
Common Stock are reserved for issuance pursuant to employee stock options, of
which options 481,156 have been granted and are outstanding on the date of this
Agreement. As of the date hereof, 1,424,934 shares of FHI Common Stock are
held by FHI as treasury stock.
(b) As of the date hereof, no Voting Debt of FHI is issued or
outstanding.
(c) All of the issued and outstanding shares of FHI Common Stock
have been, and all of the shares of FHI Common Stock issued upon conversion of
shares of Company Common Stock pursuant to Article I, when issued, will be,
duly and validly authorized and issued, are fully paid and nonassessable and
were not issued in violation of any preemptive rights of shareholders of FHI.
Except as set forth in Section 4.5(a) or in Section 4.5 of the FHI Schedule,
there are no outstanding subscriptions, options, rights, warrants, convertible
securities or other agreements or commitments obligating FHI to issue, transfer
from the treasury, deliver or sell any additional shares of FHI's capital stock
or Voting Debt or to grant, extend or enter into any such option, right,
warrant, convertible security, commitment or agreement, and no unissued shares
of FHI Common Stock are subject to any preemptive rights of shareholders of FHI
other than the preemptive rights set forth in Article Ninth of the certificate
of incorporation of FHI. There are no outstanding contractual obligations of
FHI to repurchase, redeem or otherwise acquire any outstanding shares of
capital stock of or other ownership interest in FHI.
4.6 Charter Documents. The copies of the certificate of
incorporation and by-laws of FHI delivered to Company prior to the date of this
Agreement, are true and complete copies, and such certificate of incorporation
and by-laws are in full force and effect.
4.7 SEC Documents. FHI has made available to Company a true and
complete copy of each report, schedule, registration statement and definitive
proxy statement filed by FHI with the SEC (other than reports filed pursuant to
Section 13(d) or 13(g) of the Exchange Act) since December 31, 1994 (as such
documents have since the time of their filing been amended, the "FHI SEC
Documents"), which are all the documents (other than preliminary material and
reports required pursuant to Section 13(d) or Section 13(g) of the Securities
Exchange Act of 1934 (the "Exchange Act")) that FHI was required to file with
the SEC since
such date. As of their respective dates of filing with the SEC, the FHI SEC
Documents complied in all material respects with the requirements of the
Securities Act of 1933, as amended (the "Securities Act"), or the
Exchange Act, as the case may be, and the rules and regulations of the SEC
thereunder applicable to such FHI SEC Documents, and did not contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The financial
statements of FHI included in the FHI SEC Documents complied as to form, as of
their respective dates of filing with the SEC, in all material respects with
applicable accounting requirements and with the published rules and regulations
of the SEC with respect thereto, have been prepared in accordance with GAAP
applied on a consistent basis during the periods involved (except as may be
indicated in the notes thereto or, in the case of the unaudited statements, as
permitted by Form 10-Q of the SEC) and fairly present in all material respects
the consolidated financial position of FHI and its consolidated subsidiaries as
at the dates thereof and the consolidated results of operations, changes in
stockholders' equity and cash flows of such companies for the periods then
ended. All material agreements, contracts and other documents required to be
filed as exhibits to any of the FHI SEC Documents have been so filed. FHI and
its subsidiaries have no liabilities or obligations of any nature (absolute,
accrued, contingent or otherwise) which are not fully reflected or reserved
against in the balance sheet as of December 31, 1994 included in the FHI SEC
Filings, except for liabilities and obligations incurred since such date in the
ordinary course of business consistent with past practice and not in violation
of this Agreement.
4.8 Absence of Certain Changes. Except as set forth in Section 4.8
of the FHI Schedule, since December 31, 1994, FHI and its subsidiaries have
conducted their businesses in the ordinary course, consistent with past
practice (except as expressly required to perform their obligations under this
Agreement), and there has not been since December 31, 1994 any change or event
that has had or could reasonably be expected to have, together with all other
such changes and events, a Material Adverse Effect.
4.9 Litigation. There are no suits, claims, actions or proceedings
against or affecting FHI or any of its subsidiaries pending or, to the best of
knowledge of FHI, threatened, or, in the reasonable judgment of FHI, probable
of assertion, which could reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect, or which could restrict FHI or any
subsidiary thereof from engaging in a line of business, nor is there any
judgment, decree, injunction, rule or order of any Governmental Authority or
arbitrator outstanding against FHI or any subsidiary which could have a
Material Adverse Effect or which could restrict FHI or any subsidiary from
engaging in a line of business.
4.10 Regulatory Applications. The information relating to FHI and
its subsidiaries, including Sub, provided by FHI and Sub for inclusion in any
applications filed for Regulatory Approvals and in the Proxy Statement (as
hereinafter defined) shall comply in all material respects with relevant laws
and regulations and will not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading.
4.11 Broker's and Finder's Fees. Neither FHI nor any of its
subsidiaries, including Sub, has any liability to any broker, finder or similar
agent, nor has any of them agreed to pay any brokerage fee, finder's fee or
commission, with respect hereto or to the transactions contemplated hereby.
4.12 Shareholder Approval. No vote of the shareholders of FHI is
required by the General Corporation Law of the State of Delaware, the
certificate of incorporation or by-laws of FHI or otherwise to adopt this
Agreement and approve the Merger and the other transactions contemplated
hereby. Sub has obtained all required corporate and shareholder approvals of
this Agreement and the Merger.
ARTICLE V
COVENANTS OF FHI, SUB AND COMPANY
5.1 Covenants by FHI, Sub and Company. FHI, Sub and Company shall
each:
(a) Filings and Approvals. Cooperate with the other parties in the
preparation and filing, as soon as practicable, of (i) all applications
necessary to obtain all consents, approvals, orders, resolutions or
forebearances by or from any Governmental Authorities necessary for the
consummation of the Merger and the other transactions contemplated by this
Agreement (collectively, the "Regulatory Approvals") and (ii) all other
documents necessary to obtain any other approvals and consents required to
consummate the Merger. Without limiting the generality of the foregoing, (i)
FHI and Sub, as applicable, shall provide draft copies of all required
applications to Company for review (other than any portions thereof for which
FHI or Sub has or will request confidential treatment from the applicable
regulatory authority), (ii) Company shall provide draft copies of the Proxy
Statement, and any amendments or supplements thereto, to FHI and
Sub for their review a reasonable time prior to the mailing thereof to
shareholders of Company, and (iii) FHI, Sub and Company shall promptly
apprise each other of all communications with Governmental Authorities
regarding the transactions provided for herein and related applications
and proceedings.
(b) Registration Statement.
(i) Cooperate in the preparation of a registration statement on Form
S-4 (the "Registration Statement") to be filed by FHI with the SEC in
connection with the issuance of shares of FHI Common Stock in the Merger. Each
of FHI, Sub and Company shall use all reasonable efforts to cause the
Registration Statement to be declared effective under the Securities Act as
promptly as reasonably practicable after filing thereof. FHI also shall use
all reasonable efforts to obtain all necessary state securities law or "Blue
Sky" permits and approvals required to carry out the transactions contemplated
by this Agreement. Company shall furnish to FHI all information concerning
Company, its subsidiaries, officers, directors and shareholders as may be
reasonably requested in connection with the foregoing.
(ii) Each of FHI, Sub and Company agrees, as to itself and its
subsidiaries, that none of the information supplied or to be supplied by it for
inclusion or incorporation by reference in the Registration Statement will, at
the time the Registration Statement and each amendment thereto, if any, becomes
effective under the Securities Act, contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading. Each of FHI, Sub and
Company agrees that the Registration Statement (except, in the case of Company,
with respect to portions thereof prepared by FHI, and except, in the case of
FHI, with respect to portions thereof prepared by Company) will comply as to
form in all material respects with the requirements of the Securities Act and
the rules and regulations of the SEC thereunder.
(iii) FHI will advise Company, promptly after FHI receives notice
thereof, of the time when the Registration Statement has become effective or
any supplement or amendment has been filed, of the issuance of any stop order
or the suspension of the qualification of the shares of FHI Common Stock for
offering or sale in any jurisdiction, of the initiation or threat of any
proceeding for any such purpose, or of any request by the SEC for the amendment
or supplement of the Registration Statement or for additional information.
(c) Reasonable Best Efforts. Subject to the terms and conditions
hereof, use its reasonable best efforts to take, or cause to be taken, all
appropriate action, and do, or cause to be
done, all things necessary, proper or advisable under applicable laws and
regulations to consummate and make effective the transactions contemplated
by this Agreement. Such reasonable best efforts shall include, without
limitation, (i) using reasonable best efforts to obtain all necessary
consents, approvals or waivers from third parties and Governmental
Authorities necessary for the consummation of the transactions
contemplated by this Agreement, and (ii) subject to Section 7.1(c), opposing
vigorously any litigation or administrative proceeding or
directive relating to this Agreement or the transactions contemplated hereby,
including, without limitation, promptly appealing any adverse court or agency
order.
(d) Access. During normal business hours and upon reasonable prior
notice, afford to the other parties to this Agreement and their counsel,
accountants or any other persons selected by such party full access to all its
properties, permit such persons to inspect and make copies of all stock
records, minute books, books of account, contracts, commitments and other
records, and furnish to such persons such counterpart originals or certified or
other copies of such documents or such information with respect to its
businesses and affairs as the other parties to this Agreement may from time to
time reasonably request and that the party requested to provide such
information may provide without violation of applicable law or regulation or
jeopardy to any attorney-client or similar privilege to which FHI, Sub or
Company, as the case may be, may otherwise be entitled as against third parties
other than FHI, Sub or Company; provided, however, that all information
concerning FHI, its subsidiaries (including Sub), Company and its subsidiaries
thus obtained shall be subject to the Confidentiality Agreement, dated February
15, 1996 (the "Confidentiality Agreement"), between FHI and Company.
5.2 Affirmative Covenants of Company. Company shall, and shall
cause its subsidiaries to:
(a) Conduct of Business. From and after the date of this Agreement,
(i) conduct its affairs only in the ordinary course of business consistent with
past practice, and use all reasonable efforts to preserve intact its business
organization, keep available the services of its present officers and employees
and preserve its relationships and goodwill with all persons having business
dealings with it, and (ii) maintain its and its subsidiaries' books of account
and records in accordance with GAAP applied on a basis consistent with those
principles used in preparing the financial statements heretofore delivered to
FHI and Sub, except as required by changes in applicable accounting rules and
concurred in by Company's independent public accountants.
(b) Delivery of Financial Statements. Deliver to FHI and Sub as
soon as they become available true and complete copies of any report or
statement mailed by it to shareholders or, to the extent permitted by law,
filed with Governmental Authorities subsequent to the date hereof and prior to
the Effective Time. In addition, Company shall furnish to FHI and Sub the
regularly prepared monthly financial statements of Company and its
subsidiaries.
(c) Meeting of Shareholders. Duly call a meeting of its
shareholders for the purpose of obtaining the approval of the shareholders to
the Merger, this Agreement, and all other matters necessary to consummate the
transactions contemplated by this Agreement, which meeting shall be held as
soon as practicable after the date hereof. In connection with such meeting,
the Board of Directors of Company, subject to the fiduciary duties of the
directors (determined after consultation with outside counsel to Company) based
on the information available to them at that time, shall recommend approval of
the transactions contemplated by this Agreement and indicate the determination
by the Board of Directors that the Merger is in the best interests of the
shareholders, shall not withdraw such recommendation and shall not recommend
approval of any tender offer, exchange offer, merger, consolidation, purchase
of substantial assets, recapitalization or similar transaction proposed by any
other party.
(d) Proxy Statement. Promptly prepare and, after consultation with
and review by FHI and Sub, mail to shareholders of Company the Proxy Statement.
Company represents, warrants and agrees that the Proxy Statement shall not,
(i) on the date it is first mailed to Company's shareholders, and (ii) on the
date of the meeting of shareholders with respect to the approval of this
Agreement and the Merger, contain any statement which, at the time and in light
of the circumstances under which it is made, is false or misleading with
respect to any material fact, or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein not false
or misleading or necessary to correct any statement in any earlier
communication which has become false or misleading.
5.3 Negative Covenants of Company. From the date hereof until the
Effective Time, except with the prior consent of FHI and Sub, neither Company
nor any of its subsidiaries shall:
(a) Charter. Amend or propose to amend its articles of
incorporation or charter or by-laws.
(b) Dividends. Declare or pay any dividend (whether in cash, stock
or other property) or make any other distribution in respect of its capital
stock, except that any wholly-owned
subsidiary of Company may declare and pay
cash dividends, without restriction, to Company or any of its wholly-owned
subsidiaries.
(c) Issuance of Securities. Issue, reissue, sell or acquire (or
agree to issue, reissue, sell or acquire) shares of its capital stock, other
equity securities or Voting Debt or rights, options or warrants to acquire any
such shares of stock or other equity securities or Voting Debt, except that (i)
Company and its subsidiaries may issue shares pursuant to the terms of any
Company Stock Options that were issued and outstanding on the date of this
Agreement and (ii) wholly-owned subsidiaries of Company may issue shares of
capital stock to Company or any of its wholly-owned subsidiaries.
(d) Reclassifications or Repurchases. Subdivide, combine, aggregate
in any way or reclassify any shares of its capital stock or redeem or
repurchase any shares of such capital stock.
(e) Business Combinations. Merge or consolidate (or agree to merge
or consolidate) with any other corporation, or convey to another person, firm
or corporation or encumber (or agree to convey or encumber), in one transaction
or a series of transactions, a material part of its assets or capital stock of
its subsidiaries, or acquire (or agree to acquire) all or substantially all the
assets of another person, firm or corporation, except pursuant to the Merger.
(f) Contracts; Employee Matters. (i) Enter into, amend or terminate
any material contract, arrangement, or commitment, except as required by the
terms of this Agreement; enter into, adopt, amend (except as required by law or
this Agreement) or terminate any pension, retirement, profit sharing, bonus,
incentive, welfare benefit or any other employee benefit or compensation plan
or any agreement, arrangement, plan or policy between Company or any of its
subsidiaries and one or more of their respective directors, officers or
employees; (ii) increase in any manner the compensation or fringe benefits of
any director, officer or employee or pay any benefit not required by any plan
and arrangement in effect on the date of this Agreement, or enter into any
contract, commitment or arrangement to do any of the foregoing; or (iii) enter
into or renew any contract, agreement, commitment or arrangement providing for
the payment to any director, officer or employee of Company or any of its
subsidiaries of compensation or benefits contingent, or the terms of which are
materially altered, upon the occurrence of any of the transactions contemplated
by this Agreement.
(g) Indebtedness. Incur any indebtedness for borrowed money in
excess of $100,000, or assume, guarantee, endorse or otherwise become
responsible for the obligations of any other
individual or entity, other than
deposit liabilities and assumptions, endorsements and guarantees, letters of
credit, Federal Home Loan Bank borrowings, and Fed Funds borrowings incurred
or assumed in the ordinary course of Company Bank's banking business consistent
with past practice.
(h) Investments. Make any investment in the capital stock or
securities (excluding notes issued by borrowers in respect of loans made by
Company and its subsidiaries in the ordinary course of business) of any other
person; except for (i) direct obligations of the United States of America,
(ii) obligations for which the full faith and credit of the United States of
America is pledged to provide for the payment of principal and interest, and
(iii) indebtedness described in Section 5.3(g).
(i) Business Practices. (i) Enter into any new line of business;
(ii) materially change its lending, investment, liability management and other
material management policies; or (iii) incur or commit to incur any capital
expenditures in excess of $100,000 in the aggregate for all such expenditures
from the date hereof through and including the Closing Date, or any obligations
or liabilities in connection therewith, other than capital expenditures
disclosed in Section 5.3(i) of the Company Schedule.
5.4 Notification. Each party to this Agreement shall notify the
other party promptly after becoming aware of the occurrence of, or the
impending or threatened occurrence of, any event that would constitute a breach
on its part of any obligation under this Agreement or the occurrence of any
event that would cause any representation or warranty made by it herein to be
false or misleading, or if it becomes a party or is threatened with becoming a
party to any legal or equitable proceeding or governmental investigation or
upon the occurrence of any event that would result in a change in the
circumstances of either party described in the representations and warranties
contained herein.
5.5 No Shopping. Neither Company nor any subsidiary thereof shall,
directly or indirectly, through any officer, director or agent or otherwise,
solicit, initiate, endorse, encourage, facilitate or participate in any
negotiation in respect of or cooperate with (including by way of furnishing any
nonpublic information concerning the business, properties or assets of Company,
or any subsidiary thereof) any Acquisition Proposal (as hereinafter defined);
provided, however, that the foregoing shall not prohibit Company from (i)
furnishing information concerning Company and its subsidiaries, to a person who
has made an unsolicited Acquisition Proposal pursuant to a confidentiality
agreement substantially similar to the
Confidentiality Agreement, (ii) engaging in discussions or negotiations with
such a person, or (iii) following receipt of such an unsolicited Acquisition
Proposal, failing to make or withdrawing or modifying the recommendation of
Company's Board of Directors referred to in Section 5.2(c), but in each case
referred to in clauses (i) through (iii) Company may take such actions only
to the extent that the Board of Directors of Company shall have concluded
in good faith based on the written advice of outside counsel that such action
is required to prevent the Board of Directors of Company from breaching its
fiduciary duties to the shareholders of Company under Washington law. Company
will notify FHI promptly by telephone, and thereafter promptly confirm such
notification in writing, if any such information is requested from, or any
Acquisition Proposal or inquiry with respect to any Acquisition Proposal is
received by, Company or any subsidiary thereof, and shall furnish FHI with
a copy of any written Acquisition Proposal received by Company and a summary
of the material terms of any oral Acquisition Proposal so received, including
the identity of the person making the proposal. The term "Acquisition
Proposal" means any proposal for, or any communication which may reasonably be
expected to lead to a proposal for, a merger or other business combination
involving Company or for the acquisition of a substantial equity interest in,
or a substantial portion of the assets of, Company or any subsidiary thereof.
5.6 Indemnification.
(a) FHI shall indemnify and hold harmless each present and former
director, officer, or employee of Company or any of its subsidiaries (each, an
"Indemnified Party" and, collectively, the "Indemnified Parties"), to the
fullest extent that Company would have been permitted under RCW Title 23B and
its articles of incorporation or charter and by-laws as in effect on the date
hereof, against any costs or expenses (including reasonable attorneys' fees),
judgments, fines, losses, claims, damages, and liabilities and amounts paid in
settlement (to the extent FHI consents to such settlement) in connection with
any threatened, pending or completed claim, action, suit, proceeding or
investigation, whether civil, criminal, administrative or investigative,
whether formal or informal, arising out of or pertaining to any action or
omission occurring prior to or as of the Effective Time, including, without
limitation, any which arise out of or relate to the transactions contemplated
by this Agreement. In the event of any such claim, action, suit, proceeding or
investigation, the Indemnified Party or Indemnified Parties, as applicable,
shall provide prompt written notice thereof to FHI. FHI shall have the right
to assume or participate in the defense of any such claim, action, suit,
proceeding or investigation at its own expense; provided, however, that FHI
shall not be liable for any settlement effected
without its written consent (which will not be unreasonably withheld). In the
event that FHI fails to timely assume the defense of such claim, action,
suit, proceeding or investigation, the Indemnified Parties or an Indemnified
Party, as applicable, shall have the right to appoint counsel of their own
choosing; provided, however, that FHI shall not be obligated pursuant to this
Section 5.6 to pay the fees and disbursements of more than one counsel for all
Indemnified Parties in any single action, except to the extent that, in the
opinion of counsel for the Indemnified Parties, two or more of such Indemnified
Parties have conflicting interests in the defense of such action which would
make joint representation of such Indemnified Parties inappropriate under
applicable rules of professional responsibility. Expenses incurred in
defending such claim, action, suit, proceeding or investigation shall be
paid by FHI in advance of final disposition of the same upon receipt of an
undertaking by or on behalf of such director, officer or employee to repay
such amount unless it shall ultimately be determined that the person is
entitled to be indemnified by FHI as authorized in this section.
(b) The obligations of FHI pursuant to, and the other provisions of,
this Section 5.6 shall survive the consummation of the Merger and is intended
to benefit each of the Indemnified Parties and shall be binding upon all
successors and assigns of FHI. Anything in this Section 5.6 to the contrary
notwithstanding, FHI shall not have any obligation under this Section to
indemnify any Indemnified Party against any losses, claims, damages or
liabilities that are finally judicially determined to have resulted primarily
from such Indemnified Party's own willful misconduct or gross negligence.
(c) FHI shall use all reasonable efforts to provide directors' and
officers' liability insurance covering each person who was an officer or
director of Company or any subsidiary prior to the Effective Time for a period
of three years after the Effective Time, providing coverage not materially less
favorable to such persons than that provided to such persons under Company's
existing liability insurance policies, as in effect on the date of this
Agreement; provided, however, that FHI shall not be obligated to make annual
premium payments for such insurance in excess of 125% of the annual premiums
paid as of the date hereof by Company for such insurance (the "Maximum Premium
Amount"). If the amount of the annual premiums necessary to maintain or
procure such insurance coverage exceeds the Maximum Premium Amount, FHI shall
use its best efforts to maintain the most advantageous policies of directors'
and officers' insurance obtainable for an annual premium equal to the Maximum
Premium Amount.
(d) In the event that FHI or any of its successors or assigns shall
consolidate with or merge into any other person or transfer all or
substantially all of its properties or assets to any person, proper provisions
shall be made so that the successor or assign shall assume the obligations of
FHI set forth in this Section 5.6.
(e) The indemnification and advancement of expenses provided by, or
granted pursuant to, this Section 5.6 shall not be deemed exclusive of any
other rights to which those seeking indemnification or advancement of expenses
may be entitled under any by-law, agreement, vote of shareholders or
disinterested directors or otherwise. FHI shall pay all expenses, including
attorneys' fees, that may be incurred by any Indemnified Party in enforcing the
indemnity and other obligations provided for in this Section 5.6.
5.7 Employees. It is the current intention of FHI that all existing
employees of Company Bank and its subsidiaries shall be offered the opportunity
to continue employment with Company Bank and its subsidiaries after the
Effective Time at substantially equivalent salaries as those currently paid by
Company Bank. During the two years following the Effective Time, all employees
who remain employees of the Surviving Corporation after the Effective Time
shall be eligible to participate in a package of employee benefit plans
equivalent to the package of employee benefits to be offered to FHI's other
financial institution subsidiaries located in Oregon, Washington and Idaho, and
which in the aggregate is reasonably competitive in the banking industry in
Central Washington. Employees of Company and its subsidiaries who remain in
the employ of the Surviving Corporation and its subsidiaries after the
Effective Time shall receive full credit for all purposes under such employee
benefit plans, except for the purposes of the accrual of benefits other than
vacation and sick leave benefits, for the lesser of the length of service prior
to the Effective Time with Company or any of its subsidiaries to the extent
such service would be recognized under such employee benefit plans if such
service was with FHI or its subsidiaries and the length of service that would
be recognized under similar employee benefit plans of Company and its
subsidiaries.
5.8 Affiliates. At least 40 days prior to the Closing Date, Company
shall deliver to FHI a letter identifying all persons who are, at the time this
Agreement is submitted for approval to the shareholders of Company,
"affiliates" of Company for purposes of Rule 145 under the Securities Act.
Each of FHI and Company shall use all reasonable efforts to cause each person
named in the letter delivered by Company to deliver to FHI at least 30 days
prior to the Closing Date a written agreement, substantially in the form
attached as Exhibit B.